Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
August 20
 · 
Be the first to react
Acute vs. Chronic GVHD Symptoms: What To Look For After Donor Transplant for Lymphoma Read Article...
MyLymphomaTeam

What is the 10-year relapse-free survival (RFS) for stage 2 follicular lymphoma with a FLIPI score of 0, C1 subtype, T-cell rich, and Ki-67 of 10-20%?

This is a very specific combination of factors, and the available data doesn't go into that level of detail for a precise 10-year RFS figure. However, here's what is known Show Full Answer

What is the 10-year relapse-free survival (RFS) for stage 2 follicular lymphoma with a FLIPI score of 0, C1 subtype, T-cell rich, and Ki-67 of 10-20%?

This is a very specific combination of factors, and the available data doesn't go into that level of detail for a precise 10-year RFS figure. However, here's what is known about your profile's individual factors:

Stage 2 + FLIPI 0 (Low Risk)
- Five-year survival rate for stage 2 follicular lymphoma is around 90%
- A FLIPI score of 0 places someone in the low-risk group, which carries a 5-year survival rate of about 91%
- These are very favorable indicators

What FLIPI 0 Means for Longer-Term Outlook
- 10-year overall survival across all follicular lymphoma stages ranges from 76% to 83%
- Low-risk patients generally sit at the better end of that range

Ki-67 10-20%
- This indicates a slow-growing lymphoma, which is a positive sign for long-term management

The C1 subtype and T-cell rich classification are more specialized markers that require a detailed conversation with a hematologist or oncologist, as they can influence treatment decisions and prognosis in ways that go beyond general statistics.

A specialist familiar with your full pathology report will be best placed to give a personalized RFS estimate.

August 20

Related Questions

View All
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In